Moreover, treatment of FMR1 KO mice with the BK channel open BMS-204351 corrected a variety of hyperexcitability and behavioral phenotypes, suggesting BK channels may be a valuable therapeutic target to treat FXS (Zhang et al., 2014; Carreno-Munoz et al., 2018). This evidence concerns the gene KCNMA1 and fragile X syndrome.